Abbott Laboratories buy Raymond James
Start price
14.10.24
/
50%
€107.66
Target price
14.10.25
€118.31
Performance (%)
6.26%
Price
15.07.25
€113.32
Summary
This prediction is currently active. The BUY prediction by Raymond_James shows slight gains of 6.26%. Dividends of €1.08 are taken into consideration when calculating the performance. This prediction currently runs until 14.10.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.404% | -0.404% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by Raymond_James for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $129.00 price target on the stock, up previously from $122.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Raymond_James for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€116.00
17.04.25
17.04.25
€124.96
17.04.26
17.04.26
-2.31%
15.07.25
15.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.62
25.01.24
25.01.24
€116.71
25.01.25
25.01.25
16.14%
26.01.25
26.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.30
03.01.24
03.01.24
€113.61
03.01.25
03.01.25
10.35%
04.01.25
04.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€104.02
19.10.24
19.10.24
23.73%
20.10.24
20.10.24